Cytarbel en es it fr

Cytarbel Brand names, Cytarbel Analogs

Cytarbel Brand Names Mixture

  • No information avaliable

Cytarbel Chemical_Formula

C9H13N3O5

Cytarbel RX_link

http://www.rxlist.com/cgi/generic3/cytarabine.htm

Cytarbel fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/labels.cfm?GN=cytarabine

Cytarbel msds (material safety sheet)

Cytarbel MSDS

Cytarbel Synthesis Reference

Krenitski, et al; Carbohydr.Res.; 97, 139-146(1981)

Cytarbel Molecular Weight

243.217 g/mol

Cytarbel Melting Point

212-213oC

Cytarbel H2O Solubility

Freely soluble

Cytarbel State

Solid

Cytarbel LogP

-2.712

Cytarbel Dosage Forms

Injectable solution

Cytarbel Indication

For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.

Cytarbel Pharmacology

Cytarabine is an antineoplastic anti-metabolite used in the treatment of several forms of leukemia including acute myelogenous leukemia and meningeal leukemia. Anti-metabolites masquerade as purine or pyrimidine - which become the building blocks of DNA. They prevent these substances becoming incorporated in to DNA during the "S" phase (of the cell cycle), stopping normal development and division. Cytarabine is metabolized intracellularly into its active triphosphate form (cytosine arabinoside triphosphate). This metabolite then damages DNA by multiple mechanisms, including the inhibition of alpha-DNA polymerase, inhibition of DNA repair through an effect on beta-DNA polymerase, and incorporation into DNA. The latter mechanism is probably the most important. Cytotoxicity is highly specific for the S phase of the cell cycle.

Cytarbel Absorption

Less than 20% of the orally administered dose is absorbed from the gastrointestinal tract.

Cytarbel side effects and Toxicity

Cytarabine syndrome may develop - it is characterized by fever, myalgia, bone pain, occasionally chest pain, maculopapular rash, conjunctivitis, and malaise.

Cytarbel Patient Information

This medicine is a type of chemotherapy for treating cancers of the
blood and certain other cancers. This medicine interfers with the
way cancer cells grow, Take your doses on a regular scheduled time
and DO NOT take this medicine more often than directed by your health
care provider. Finish the full course prescribed by your health care
provider. DO NOT stop taking this medicine unless diredted to do so
by your health care provider. While taking this medicine, you make
get infection more easily. Call your doctor if you get a fever, chills,
or sore throat. Drink plenty of water with this medicine.

Cytarbel Organisms Affected

Humans and other mammals